Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States
August 9, 2026
Our group's manufacturing facility in Vietnam was inspected by the U.S. Food and Drug Administration (FDA), and we received some findings regarding our manufacturing control.
Following discussions with the FDA, as a precautionary measure, we are conducting a voluntary recall of affected lots of eye drops manufactured in Vietnam for the U.S. market, targeting inventory (estimated at approximately 130,000 units) held by U.S. retailers and distributors.
We apologize for any concern this may have caused our customers. Regarding eye drops manufactured at the affected facility, we conduct prescribed quality tests, including sterility testing, on every lot, and only products that meet all shipping standards are shipped.
Furthermore, for products destined for Japan, we conduct quality testing on all lots again upon domestic receipt to ensure further quality verification.
Currently, no reports of health problems related to this matter have been confirmed.
We sincerely apologize for the worry we have caused you.
Our group will continue to ensure thorough manufacturing management and quality assurance systems are in place, and will strive for further quality improvement.
We would appreciate your continued patronage of our products.